Humana Expands Value-Based Oncology Care Through New Agreement with Thyme Care

LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (NYSE: HUM), a leading health and well-being company, today introduced a new value-based care agreement with Thyme Care to provide comprehensive cancer care support for eligible Humana Medicare Advantage members. Value-based care is a holistic, patient-centered model designed to improve patient health outcomes and quality of life while helping to make healthcare more affordable and accessible.

Cancer is the second-leading cause of death in the United States, with devastating physical, emotional, and financial consequences. Humana’s collaboration with Thyme Care is designed to address these challenges through 24/7 virtual care navigation, data-driven insights that empower Care Teams to intervene early, and provider-led pharmacy interventions that reduce patient out-of-pocket costs. This proactive approach to cancer care minimizes care gaps, reduces costly and unnecessary expenditures, and supports patients while managing the complexities and costs of cancer care.

 

READ FULL PRESS RELEASE HERE